newsfilter
← Latest News
GlobeNewswire·

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer

BOULDER, Colo., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. ("Fresh Tracks" or the "Company") (NASDAQ:FRTX), a clinical-stage pharmaceutical company aiming to disrupt existing treatment paradigms